Gore & Associates, Inc. (“Gore”), a global materials science company, recently announced the commercial launch of the 0.5 mL ...

The new offering is specially designed for prefilled syringes used in various applications, including ophthalmic intravitreal injections, and complements the GORE IMPROJECT 1 mLL plunger which ...

Celltrion announces US FDA approval of additional presentation of Steqeyma, expanding dosing options for paediatric patients: Incheon, South Korea Tuesday, June 17, 2025, 16:00 Hr ...

W. L. Gore & Associates, Inc. (“Gore”), a global materials science company, recently announced the commercial launch of the 0.5 mL silicone-free* GORE® IMPROJECT® Syringe Plunger within its ...

This valuable study presents a novel approach to enhance the therapeutic potential of mesenchymal stromal cells (MSCs) by genetically modifying their glycogen synthesis pathway, resulting in increased ...

The company has asked users to monitor patients frequently to ensure the appropriate infusion is being delivered.

Organon and Samsung Bioepis' HADLIMA granted FDA interchangeability designation approval for all high- and-low concentration presentations.

New findings reveal RP1 combined with nivolumab enhances response rates in advanced melanoma, especially with deep tumor ...